{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:58:12Z","timestamp":1790740692107,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12975-025-01389-3","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:46:57Z","timestamp":1760158017000},"page":"2350-2363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hematoma Resorption in Intracerebral Hemorrhage: A Translational Overview on Pathophysiology, Biomarkers, and Innovative Therapies"],"prefix":"10.1007","volume":"16","author":[{"given":"Laurent","family":"Puy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mazzoleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neshika","family":"Samarasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hsi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gaberel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"B\u00e9r\u00e9zowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167\u201376. https:\/\/doi.org\/10.1016\/S1474-4422(09)70340-0.","journal-title":"Lancet Neurol"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0140-6736(24)00702-5","volume":"403","author":"J Beck","year":"2024","unstructured":"Beck J, Fung C, Strbian D, B\u00fctikofer L, Z\u2019Graggen WJ, Lang MF, Beyeler S, Gralla J, Ringel F, Schaller K, et al. Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial. Lancet. 2024;403:2395\u2013404.","journal-title":"Lancet"},{"key":"1389_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","volume":"11","author":"RF Keep","year":"2012","unstructured":"Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720\u201331.","journal-title":"Lancet Neurol"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01079","volume":"10","author":"Z Shao","year":"2019","unstructured":"Shao Z, Tu S, Shao A. Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage. Front Pharmacol. 2019;10:1\u20138.","journal-title":"Front Pharmacol"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12975-019-00745-4","volume":"11","author":"C Tao","year":"2020","unstructured":"Tao C, Keep RF, Xi G, Hua Y. CD47 blocking antibody accelerates hematoma clearance after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2020;11:541\u201351.","journal-title":"Transl Stroke Res"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.4049\/jimmunol.1400054","volume":"192","author":"H Fang","year":"2014","unstructured":"Fang H, Chen J, Lin S, Wang P, Wang Y, Xiong X, Yang Q. CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling. J Immunol. 2014;192:5984\u201392.","journal-title":"J Immunol"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","volume":"393","author":"DF Hanley","year":"2019","unstructured":"Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, et al. Minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label phase 3 trial with blinded endpoint. Lancet [Internet]. 2019;393:1021\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(19)30195-3.","journal-title":"Lancet [Internet]"},{"key":"1389_CR8","doi-asserted-by":"publisher","unstructured":"Morotti A, Boulouis G, Dowlatshahi D, Li Q, Shamy M, Salman RA, Rosand J, Cordonnier C, Goldstein JN, Charidimou A. Intracerebral haemorrhage expansion\u202f: definitions , predictors , and prevention. Lancet Neurol [Internet]. 2022;i:1\u201312. https:\/\/doi.org\/10.1016\/S1474-4422(22)00338-6","DOI":"10.1016\/S1474-4422(22)00338-6"},{"key":"1389_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1212\/WNL.0b013e3182143317","volume":"76","author":"D Dowlatshahi","year":"2011","unstructured":"Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238\u201344.","journal-title":"Neurology"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00005072-197107000-00015","volume":"30","author":"CM Fisher","year":"1971","unstructured":"Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536\u201350. https:\/\/doi.org\/10.1097\/00005072-197107000-00015.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/nan.12733","volume":"47","author":"L Puy","year":"2021","unstructured":"Puy L, Corseaux D, Perbet R, Deramecourt V, Cordonnier C, B\u00e9r\u00e9zowski V. Neutrophil extracellular traps (NETs) infiltrate haematoma and surrounding brain tissue after intracerebral haemorrhage: a post-mortem study. Neuropathol Appl Neurobiol. 2021;47:867\u201377.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41582-018-0020-0","volume":"14","author":"D Bulters","year":"2018","unstructured":"Bulters D, Gaastra B, Zolnourian A, Alexander S, Ren D, Blackburn SL, Borsody M, Dor\u00e9 S, Galea J, Iihara K, et al. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications. Nat Rev Neurol. 2018;14:416\u201332. https:\/\/doi.org\/10.1038\/s41582-018-0020-0.","journal-title":"Nat Rev Neurol"},{"key":"1389_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/01.STR.0000247868.97078.10","volume":"38","author":"Y Hua","year":"2007","unstructured":"Hua Y, Keep RF, Hoff JT, Xi G. Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke. 2007;38:759\u201362.","journal-title":"Stroke"},{"key":"1389_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2020.591874","volume":"14","author":"Q Bai","year":"2020","unstructured":"Bai Q, Liu J, Wang G. Ferroptosis, a regulated neuronal cell death type after intracerebral hemorrhage. Front Cell Neurosci. 2020;14:1\u20139.","journal-title":"Front Cell Neurosci"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.25732","volume":"88","author":"L Sondag","year":"2020","unstructured":"Sondag L, Schreuder FHBM, Boogaarts HD, Rovers MM, Vandertop WP, Dammers R, Klijn CJM. Neurosurgical intervention for supratentorial intracerebral hemorrhage. Ann Neurol. 2020;88:239\u201350.","journal-title":"Ann Neurol"},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(16)32410-2","volume":"389","author":"DF Hanley","year":"2017","unstructured":"Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, Dawson J, Gandhi D, Moukd AW, Mayo SW, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389:603\u201311.","journal-title":"Lancet."},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","volume":"365","author":"AD Mendelow","year":"2005","unstructured":"Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387\u201397.","journal-title":"Lancet"},{"key":"1389_CR18","doi-asserted-by":"publisher","unstructured":"Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM, Ii S. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas ( STICH II ): a randomised trial. Lancet [Internet]. 382:397\u2013408. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(13)60986-1.","DOI":"10.1016\/S0140-6736(13)60986-1"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/neuros\/nyaa572","volume":"88","author":"SP Polster","year":"2021","unstructured":"Polster SP, Carri\u00f3n-Penagos J, Lyne SB, Gregson BA, Cao Y, Thompson RE, Stadnik A, Girard R, Money PL, Lane K, et al. Intracerebral hemorrhage volume reduction and timing of intervention versus functional benefit and survival in the MISTIE III and STICH trials. Neurosurgery. 2021;88:961\u201370.","journal-title":"Neurosurgery"},{"key":"1389_CR20","doi-asserted-by":"crossref","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53:e282\u2013e361.","DOI":"10.1161\/STR.0000000000000407"},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/STROKEAHA.123.045880","volume":"55","author":"S Vandelanotte","year":"2024","unstructured":"Vandelanotte S, Fran\u00e7ois O, Desender L, Staessens S, Vanhoorne A, Van Gool F, Tersteeg C, Vanhoorelbeke K, Vanacker P, Andersson T, et al. R-tPA resistance is specific for platelet-rich stroke thrombi and can be overcome by targeting nonfibrin components. Stroke. 2024;55:1181\u201390.","journal-title":"Stroke"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2308440","volume":"390","author":"G Pradilla","year":"2024","unstructured":"Pradilla G, Ratcliff JJ, Hall AJ, Saville BR, Allen JW, Paulon G, McGlothlin A, Lewis RJ, Fitzgerald M, Caveney AF, et al. Trial of early minimally invasive removal of intracerebral hemorrhage. N Engl J Med. 2024;390:1277\u201389.","journal-title":"N Engl J Med"},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/jcmm.13441","volume":"22","author":"G Wang","year":"2018","unstructured":"Wang G, Wang L, Sun XG, Tang J. Haematoma scavenging in intracerebral haemorrhage\u202f: from mechanisms to the clinic current understanding of the mechanisms underlying ICH-induced brain injury phagocytosis in haematoma resolution. J Cell Mol Med. 2018;22:768\u201377.","journal-title":"J Cell Mol Med"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1161\/STROKEAHA.121.037751","volume":"53","author":"L Puy","year":"2022","unstructured":"Puy L, Perbet R, Figeac M, Duch\u00eane B, Deramecourt V, Cordonnier C, B\u00e9r\u00e9zowski V. Brain peri-hematomal area, a strategic interface for blood clearance: a human neuropathological and transcriptomic study. Stroke. 2022;53:2026\u201335.","journal-title":"Stroke"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI95612","volume":"128","author":"C-F Chang","year":"2018","unstructured":"Chang C-F, Goods BA, Askenase MH, Hammond MD, Renfroe SC, Steinschneider AF, Landreneau MJ, Ai Y, Beatty HE, da Costa LHA, et al. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage. J Clin Invest. 2018;128:607\u201324.","journal-title":"J Clin Invest"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0271678X17753590","volume":"38","author":"DA Wilkinson","year":"2018","unstructured":"Wilkinson DA, Keep RF, Hua Y, Xi G. Hematoma clearance as a therapeutic target in intracerebral hemorrhage: from macro to micro. J Cereb Blood Flow Metab. 2018;38:741\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1389_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013146","author":"S Cao","year":"2016","unstructured":"Cao S, Zheng M, Hua Y, Chen G. Hematoma changes during clot resolution after experimental intracerebral hemorrhage. Stroke. 2016. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013146.","journal-title":"Stroke"},{"key":"1389_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nbd.2015.12.015","volume":"87","author":"JJ Flores","year":"2016","unstructured":"Flores JJ, Klebe D, Rolland WB, Lekic T, Krafft PR, Zhang JH. PPAR\u03b3-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. Neurobiol Dis. 2016;87:124\u201333.","journal-title":"Neurobiol Dis"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2017.10.021","volume":"128","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen Q, Tan Q, Feng Z, He Z, Tang J, Feng H, Zhu G, Chen Z. Simvastatin accelerates hematoma resolution after intracerebral hemorrhage in a PPAR\u03b3-dependent manner. Neuropharmacology. 2018;128:244\u201354.","journal-title":"Neuropharmacology"},{"key":"1389_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cns.12350","volume":"21","author":"XR Zhao","year":"2015","unstructured":"Zhao XR, Gonzales N, Aronowski J. Pleiotropic role of PPAR\u03b3 in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-\u03baB. CNS Neurosci Ther. 2015;21:357\u201366.","journal-title":"CNS Neurosci Ther"},{"key":"1389_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/jnc.12974","volume":"133","author":"X Zhao","year":"2015","unstructured":"Zhao X, Sun G, Ting SM, Song S, Zhang J, Edwards NJ, Aronowski J. Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance. J Neurochem. 2015;133:144\u201352.","journal-title":"J Neurochem"},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/STROKEAHA.118.024578","volume":"50","author":"C Jing","year":"2019","unstructured":"Jing C, Bian L, Wang M, Keep RF, Xi G, Hua Y. Enhancement of hematoma clearance with CD47 blocking antibody in experimental intracerebral hemorrhage. Stroke. 2019;50:1539\u201347.","journal-title":"Stroke"},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012;109:6662\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1389_CR34","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1200\/JCO.2016.34.15_suppl.3019","volume":"34","author":"BI Sikic","year":"2016","unstructured":"Sikic BI, Narayanan S, Colevas AD, Padda SK, Fisher GA, Supan D, Wakelee HA, Aoki R, Pegram MD, Villalobos VM, et al. A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers. J Clin Oncol. 2016;34:3019\u20133019.","journal-title":"J Clin Oncol"},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.21097","volume":"61","author":"X Zhao","year":"2007","unstructured":"Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, Grotta JC, Aronowski J. Hematoma resolution as a target for intracerebral hemorrhage treatment\u202f: role for peroxisome proliferator-activated receptor \u2425 in microglia \/ macrophages. Ann Neurol. 2007;61:352\u201362.","journal-title":"Ann Neurol"},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/STROKEAHA.108.533158","volume":"40","author":"X Zhao","year":"2009","unstructured":"Zhao X, Grotta J, Gonzales N, Aronowski J. Hematoma resolution as a therapeutic target: the role of microglia\/macrophages. Stroke. 2009;40:92\u20134.","journal-title":"Stroke"},{"key":"1389_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1471-4159.2006.04376.x","volume":"101","author":"K Tureyen","year":"2007","unstructured":"Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem. 2007;101:41\u201356.","journal-title":"J Neurochem"},{"key":"1389_CR38","doi-asserted-by":"crossref","unstructured":"Gonzales N, Sangha N, Cai C, Hasan KM, Ayish D, Olowu A, Sline MR, Pandurengan R, Bowry R, Hossain MM, et al. The safety of pioglitazone for hematoma resolution in intracerebral hemorrhage (SHRINC): a randomised, blinded, phase 2, safety trial. 2018. Available SSRN https:\/\/doi.org\/www.ssrn.com\/abstract=3260800 or http:\/\/doi.org\/10.2139\/ssrn.3260800.","DOI":"10.2139\/ssrn.3260800"},{"key":"1389_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-024-01278-1","author":"A Zolnourian","year":"2024","unstructured":"Zolnourian A, Garland P, Holton P, Arora M, Rhodes J, Uff C, Birch T, Howat D, Franklin S, Galea I, et al. A randomised controlled trial of SFX-01 after subarachnoid haemorrhage \u2014 the SAS study. Transl Stroke Res. 2024. https:\/\/doi.org\/10.1007\/s12975-024-01278-1.","journal-title":"Transl Stroke Res"},{"key":"1389_CR40","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1073\/pnas.2018497117","volume":"117","author":"J Xu","year":"2020","unstructured":"Xu J, Chen Z, Yu F, Liu H, Ma C, Xie D, Hu X, Leak RK, Chou SHY, Stetler RA, et al. IL-4\/STAT6 signaling facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice. Proc Natl Acad Sci U S A. 2020;117:32679\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1389_CR41","first-page":"1","volume":"16","author":"J Liu","year":"2022","unstructured":"Liu J, Zhu Z, Leung GKK. Erythrophagocytosis by microglia\/macrophage in intracerebral hemorrhage: from mechanisms to translation. Front Cell Neurosci. 2022;16:1\u201313.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1389_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12975-016-0505-3","volume":"8","author":"G Dang","year":"2017","unstructured":"Dang G, Yang Y, Wu G, Hua Y, Keep RF, Xi G. Early erythrolysis in the hematoma after experimental intracerebral hemorrhage. Transl Stroke Res. 2017;8(2):174\u201382.","journal-title":"Transl Stroke Res"},{"key":"1389_CR43","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/STROKEAHA.117.016850","volume":"48","author":"R Liu","year":"2017","unstructured":"Liu R, Cao S, Hua Y, Keep RF, Huang Y, Xi G. CD163 expression in neurons after experimental intracerebral hemorrhage. Stroke. 2017;48:1369\u201375.","journal-title":"Stroke"},{"key":"1389_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12975-017-0535-5","volume":"8","author":"T Garton","year":"2017","unstructured":"Garton T, Keep RF, Hua Y, Xi G. CD163, a hemoglobin\/haptoglobin scavenger receptor, after intracerebral hemorrhage: functions in microglia\/macrophages versus neurons. Transl Stroke Res. 2017;8:612\u20136.","journal-title":"Transl Stroke Res"},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0271678X17701459","volume":"38","author":"JL Leclerc","year":"2018","unstructured":"Leclerc JL, Lampert AS, Loyola Amador C, Schlakman B, Vasilopoulos T, Svendsen P, Moestrup SK, Dor\u00e9 S. The absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes. J Cereb Blood Flow Metab. 2018;38:262\u201373.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1389_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1115726","author":"P Fu","year":"2023","unstructured":"Fu P, Zhang M, Wu M, Zhou W, Yin X, Chen Z, Dan C. Research progress of endogenous hematoma absorption after intracerebral hemorrhage. Front Neurol. 2023. https:\/\/doi.org\/10.3389\/fneur.2023.1115726.","journal-title":"Front Neurol"},{"key":"1389_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04212-6","author":"M You","year":"2022","unstructured":"You M, Long C, Wan Y, Guo H, Shen J, Li M, He Q, Hu B. Neuron derived fractalkine promotes microglia to absorb hematoma via CD163\/HO-1 after intracerebral hemorrhage. Cell Mol Life Sci. 2022. https:\/\/doi.org\/10.1007\/s00018-022-04212-6.","journal-title":"Cell Mol Life Sci"},{"key":"1389_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2014.00061","volume":"5","author":"D Chiabrando","year":"2014","unstructured":"Chiabrando D, Vinchi F, Fiorito V, Mercurio S, Tolosano E. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol. 2014;5:1\u201324.","journal-title":"Front Pharmacol"},{"key":"1389_CR49","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/0271678X16654494","volume":"37","author":"G Wang","year":"2017","unstructured":"Wang G, Manaenko A, Shao A, Ou Y, Yang P, Budbazar E, Nowrangi D, Zhang JH, Tang J. Low-density lipoprotein receptor-related protein-I facilitates heme scavenging after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2017;37:1299\u2013310.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.expneurol.2019.05.003","volume":"318","author":"S Hu","year":"2019","unstructured":"Hu S, Hua Y, Keep RF, Feng H, Xi G. Deferoxamine therapy reduces brain hemin accumulation after intracerebral hemorrhage in piglets. Exp Neurol. 2019;318:244\u201350.","journal-title":"Exp Neurol"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1474-4422(08)70041-3","volume":"7","author":"CS Kidwell","year":"2008","unstructured":"Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7:256\u201367.","journal-title":"Lancet Neurol"},{"key":"1389_CR52","first-page":"1","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Liu Y, Wei R, Khan S, Zhang R, Zhang Y, Yong VW, Xue M. Iron neurotoxicity and protection by deferoxamine in intracerebral hemorrhage. Front Mol Neurosci. 2022;15:1\u20136.","journal-title":"Front Mol Neurosci"},{"key":"1389_CR53","first-page":"1","volume":"10","author":"Y Yu","year":"2015","unstructured":"Yu Y, Zhao W, Zhu C, Kong Z, Xu Y, Liu G, Gao X. The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage. PLoS ONE. 2015;10:1\u201313.","journal-title":"PLoS ONE"},{"key":"1389_CR54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3171\/jns.2004.100.4.0672","volume":"100","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100:672\u20138. https:\/\/doi.org\/10.3171\/jns.2004.100.4.0672.","journal-title":"J Neurosurg"},{"key":"1389_CR55","doi-asserted-by":"crossref","unstructured":"Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke [Internet]. 2011;42:3067\u20133074. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.111.617589","DOI":"10.1161\/STROKEAHA.111.617589"},{"key":"1389_CR56","doi-asserted-by":"crossref","unstructured":"Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, Greenberg SM, James ML, Singh V, Clark WM, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol [Internet]. 2019;18:428\u2013438. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442219300699","DOI":"10.1016\/S1474-4422(19)30069-9"},{"key":"1389_CR57","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1161\/STROKEAHA.121.037298","volume":"53","author":"L Foster","year":"2022","unstructured":"Foster L, Robinson L, Yeatts SD, Conwit RA, Shehadah A, Lioutas V, Selim M. Effect of deferoxamine on trajectory of recovery after intracerebral hemorrhage: a post hoc analysis of the i-DEF trial. Stroke. 2022;53:2204\u201310.","journal-title":"Stroke"},{"key":"1389_CR58","doi-asserted-by":"crossref","unstructured":"Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (Hi-Def) trial: rationale, design, and methods. Neurocrit Care [Internet]. 2013;19:257\u2013266. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf","DOI":"10.1007\/s12028-013-9861-y"},{"key":"1389_CR59","first-page":"1","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Yong VW, Xue M. Revisiting minocycline in intracerebral hemorrhage: mechanisms and clinical translation. Front Immunol. 2022;13:1\u201313.","journal-title":"Front Immunol"},{"key":"1389_CR60","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","volume":"48","author":"AY Fouda","year":"2017","unstructured":"Fouda AY, Newsome AS, Spellicy S, Waller JL, Zhi W, Hess DC, Ergul A, Edwards DJ, Fagan SC, Switzer JA. Minocycline in acute cerebral hemorrhage an early phase randomized trial. Stroke. 2017;48:2885\u20137.","journal-title":"Stroke"},{"key":"1389_CR61","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1161\/01.STR.0000103140.52838.45","volume":"34","author":"J Wu","year":"2003","unstructured":"Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34:2964\u20139.","journal-title":"Stroke"},{"key":"1389_CR62","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/STROKEAHA.123.043799","volume":"54","author":"TB Helmuth","year":"2023","unstructured":"Helmuth TB, Kumari R, Palsa K, Neely EB, Slagle-Webb B, Simon SD, Connor JR. Common mutation in the HFE gene modifies recovery after intracerebral hemorrhage. Stroke. 2023;54:2886\u201394.","journal-title":"Stroke"},{"key":"1389_CR63","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/STROKEAHA.121.037834","volume":"29","author":"HH Tsai","year":"2022","unstructured":"Tsai HH, Hsieh YC, Lin JS, Kuo ZT, Ho CY, Chen CH, Chang CF. Functional investigation of meningeal lymphatic system in experimental intracerebral hemorrhage. Stroke. 2022;29:987\u201398.","journal-title":"Stroke"},{"key":"1389_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0205436","volume":"13","author":"AC Klahr","year":"2018","unstructured":"Klahr AC, Kate M, Kosior J, Buck B, Shuaib A, Emery D, Butcher K. Early hematoma retraction in intracerebral hemorrhage is uncommon and does not predict outcome. PLoS ONE. 2018;13:1\u201312.","journal-title":"PLoS ONE"},{"key":"1389_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2013.02.009","volume":"327","author":"GG Luo","year":"2013","unstructured":"Luo GG, Ramchurn A, Chen YF, Li YB, Yuan BB, Huo K, Yuan XY, Yang J. Early predictors of hematoma resorption rate in medically treated patients with spontaneous supratentorial hemorrhage. J Neurol Sci. 2013;327:55\u201360. https:\/\/doi.org\/10.1016\/j.jns.2013.02.009.","journal-title":"J Neurol Sci"},{"key":"1389_CR66","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4103\/1673-5374.187047","volume":"11","author":"WJ Xie","year":"2016","unstructured":"Xie WJ, Yu HQ, Zhang Y, Liu Q, Meng HM. CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage. Neural Regen Res. 2016;11:1122\u20137.","journal-title":"Neural Regen Res"},{"key":"1389_CR67","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/STROKEAHA.114.007343","volume":"46","author":"AJS Webb","year":"2015","unstructured":"Webb AJS, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, Mayo S, Rosenblum M, Ziai W, Zuccarrello M, et al. Accuracy of the ABC\/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke. 2015;46:2470\u20136.","journal-title":"Stroke"},{"key":"1389_CR68","doi-asserted-by":"publisher","unstructured":"Zhang T, Wen D, Wang X, Yu Y, Wang C, Tao C, et al. Peripheral monocyte count is associated with hematoma clearance after intracerebral hemorrhage\u202f: a multicenter retrospective study. PREPRINT (Version 1) available at Research Square. 2022.\u00a0https:\/\/doi.org\/10.21203\/rs.3.rs-2317975\/v1.","DOI":"10.21203\/rs.3.rs-2317975\/v1"},{"key":"1389_CR69","doi-asserted-by":"publisher","DOI":"10.1159\/000540099","author":"N Samarasekera","year":"2024","unstructured":"Samarasekera N, Ferguson K, Parry-Jones AR, Rodrigues M, Loan J, Moullaali TJ, Hughes J, Shoveller L, Wardlaw J, McColl B, et al. Perihaematomal oedema evolution over 2 weeks after spontaneous intracerebral haemorrhage and association with outcome: a prospective cohort study. Cerebrovasc Dis. 2024. https:\/\/doi.org\/10.1159\/000540099.","journal-title":"Cerebrovasc Dis"},{"key":"1389_CR70","doi-asserted-by":"crossref","unstructured":"Alastair JS Webb, DPhil, Natalie L Ullman, BS, Tim C Morgan, MPH, John Muschelli S, Joshua Kornbluth, MD, Issam A Awad, MD, Stephen Mayo, MD, Michael Rosenblum P, Wendy Ziai, MD, Mario Zuccarrello, MD, Francois Aldrich, MD, Sayona John, MD S, Harnof, MD, George Lopez, MD, William C Broaddus, MD, Christine Wijman, MD P, Vespa, MD, Ross Bullock, MD, PhD, Stephen J Haines, MD, Salvador Cruz-Flores, MD S, Tuhrim, MD, Michael D Hill, MD, Raj Narayan, MD, and Daniel F Hanley M. Accuracy of the ABC\/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, CLEAR III. Stroke. 2015;49:2470\u20132476.","DOI":"10.1161\/STROKEAHA.114.007343"},{"key":"1389_CR71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1161\/STROKEAHA.113.003701","volume":"45","author":"F Macellari","year":"2014","unstructured":"Macellari F, Paciaroni M, Agnelli G, Caso V. Neuroimaging in intracerebral hemorrhage. Stroke. 2014;45:903\u20138.","journal-title":"Stroke"},{"key":"1389_CR72","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1161\/STROKEAHA.107.506683","volume":"39","author":"RA Knight","year":"2008","unstructured":"Knight RA, Han Y, Nagaraja TN, Whitton P, Ding J, Chopp M, Seyfried DM. Temporal MRI assessment of intracerebral hemorrhage in rats. Stroke. 2008;39:2596\u2013602.","journal-title":"Stroke"},{"key":"1389_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/961461","author":"M Li","year":"2012","unstructured":"Li M, Akhavan-Sharif RM, Friedlander RM, Du R, Thiex R. What sequences on high-field MR best depict temporal resolution of experimental ICH and edema formation in mice? J Biomed Biotechnol. 2012. https:\/\/doi.org\/10.1155\/2012\/961461.","journal-title":"J Biomed Biotechnol"},{"key":"1389_CR74","doi-asserted-by":"crossref","unstructured":"Puy L, Kuchcinski G, Leboullenger C, Auger F, Cordonnier C, B\u00e9r\u00e9zowski V. Multimodal and serial MRI monitors brain peri-hematomal injury and repair mechanisms after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab.\u00a02025;45:140\u201352.","DOI":"10.1177\/0271678X241270198"},{"key":"1389_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.764718","volume":"12","author":"ME Haque","year":"2021","unstructured":"Haque ME, Boren SB, Arevalo OD, Gupta R, George S, Parekh MA, Zhao X, Aronowski J, Savitz SI. Longitudinal, quantitative, multimodal MRI evaluation of patients with intracerebral hemorrhage over the first year. Front Neurol. 2021;12:1\u201311.","journal-title":"Front Neurol"},{"key":"1389_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-022-00735-3","author":"F Schlunk","year":"2022","unstructured":"Schlunk F, Kuthe J, Harmel P, Audebert H, Hanning U, Bohner G, Scheel M, Kleine J, Nawabi J. Volumetric accuracy of different imaging modalities in acute intracerebral hemorrhage. BMC Med Imaging. 2022. https:\/\/doi.org\/10.1186\/s12880-022-00735-3.","journal-title":"BMC Med Imaging"},{"key":"1389_CR77","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/cns.13395","volume":"26","author":"J Wei","year":"2020","unstructured":"Wei J, Novakovic N, Chenevert TL, Xi G, Keep RF, Pandey AS, Chaudhary N. Perihematomal brain tissue iron concentration measurement by MRI in patients with intracerebral hemorrhage. CNS Neurosci Ther. 2020;26:896\u2013901.","journal-title":"CNS Neurosci Ther"},{"key":"1389_CR78","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/cns.13693","volume":"27","author":"N Novakovic","year":"2021","unstructured":"Novakovic N, Wilseck ZM, Chenevert TL, Xi G, Keep RF, Pandey AS, Chaudhary N. Assessing early erythrolysis and the relationship to perihematomal iron overload and white matter survival in human intracerebral hemorrhage. CNS Neurosci Ther. 2021;27:1118\u201326.","journal-title":"CNS Neurosci Ther"},{"key":"1389_CR79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12975-018-0630-2","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu R, Li H, Hua Y, Keep RF, Xiao J, Xi G, Huang Y. Early hemolysis within human intracerebral hematomas: an MRI study. Transl Stroke Res. 2019;10:52\u20136.","journal-title":"Transl Stroke Res"},{"key":"1389_CR80","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/STROKEAHA.122.037155","volume":"54","author":"SN Ohashi","year":"2023","unstructured":"Ohashi SN, DeLong JH, Kozberg MG, Mazur-Hart DJ, van Veluw SJ, Alkayed NJ, Sansing LH. Role of inflammatory processes in hemorrhagic stroke. Stroke. 2023;54:605\u201319.","journal-title":"Stroke"},{"key":"1389_CR81","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","volume":"61","author":"P Jain","year":"2020","unstructured":"Jain P, Chaney AM, Carlson ML, Jackson IM, Rao A, James ML. Neuroinflammation PET imaging: current opinion and future directions. J Nucl Med. 2020;61:1107\u201312.","journal-title":"J Nucl Med"},{"key":"1389_CR82","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-0716-1712-0_17","volume":"173","author":"EL Werry","year":"2022","unstructured":"Werry EL, Bright FM, Kassiou M. TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders. NeuroMethods. 2022;173:407\u201327.","journal-title":"NeuroMethods"},{"key":"1389_CR83","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jon.12477","volume":"28","author":"KA Abid","year":"2018","unstructured":"Abid KA, Sobowale OA, Parkes LM, Naish J, Parker GJM, du Plessis D, Brough D, Barrington J, Allan SM, Hinz R, et al. Assessing inflammation in acute intracerebral hemorrhage with PK11195 PET and dynamic contrast-enhanced MRI. J Neuroimaging. 2018;28:158\u201361.","journal-title":"J Neuroimaging"},{"key":"1389_CR84","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1089\/ars.2012.4834","volume":"18","author":"A Etzerodt","year":"2013","unstructured":"Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18:2352\u201363.","journal-title":"Antioxid Redox Signal"},{"key":"1389_CR85","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/acn3.485","volume":"4","author":"M Roy-O\u2019Reilly","year":"2017","unstructured":"Roy-O\u2019Reilly M, Zhu L, Atadja L, Torres G, Aronowski J, McCullough L, Edwards NJ. Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema. Ann Clin Transl Neurol. 2017;4:793\u2013800.","journal-title":"Ann Clin Transl Neurol"},{"key":"1389_CR86","first-page":"1","volume":"14","author":"CL Wang","year":"2022","unstructured":"Wang CL, Yan XJ, Zhang CL, Xu YW. Elevated serum nuclear factor erythroid 2-related factor 2 levels contribute to a poor prognosis after acute supratentorial intracerebral hemorrhage: a prospective cohort study. Front Aging Neurosci. 2022;14:1\u201313.","journal-title":"Front Aging Neurosci"},{"key":"1389_CR87","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/00004647-200206000-00007","volume":"22","author":"Y Jiang","year":"2002","unstructured":"Jiang Y, Wu J, Keep RF, Hua Y, Hoff JT, Xi G. Hypoxia-inducible factor-1\u03b1 accumulation in the brain after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2002;22:689\u201396.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1389_CR88","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/TCRM.S313433","volume":"17","author":"Y Cai","year":"2021","unstructured":"Cai Y, Zhuang YK, Wu XY, Dong XQ, Du Q, Yu WH, Wang KY, Hu W, Zheng YK. Serum hypoxia-inducible factor 1alpha levels correlate with outcomes after intracerebral hemorrhage. Ther Clin Risk Manag. 2021;17:717\u201326.","journal-title":"Ther Clin Risk Manag"},{"key":"1389_CR89","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.116.021881","volume":"134","author":"XY Xiong","year":"2016","unstructured":"Xiong XY, Liu L, Wang FX, Yang YR, Hao JW, Wang PF, Zhong Q, Zhou K, Xiong A, Zhu WY, et al. Toll-like receptor 4\/MyD88-mediated signaling of hepcidin expression causing brain iron accumulation, oxidative injury, and cognitive impairment after intracerebral hemorrhage. Circulation. 2016;134:1025\u201338.","journal-title":"Circulation"},{"key":"1389_CR90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.copbio.2016.04.021","volume":"40","author":"L Nih","year":"2016","unstructured":"Nih L, Carmichael TS, Segura T. Hydrogels for brain repair after stroke: an emerging treatment option. Curr Opin Biotechnol. 2016;40:155\u201363.","journal-title":"Curr Opin Biotechnol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-025-01389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:02:38Z","timestamp":1762632158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-025-01389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s12975-025-01389-3","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Disclosures: V.M, N.S, HH.T and T.G : none A.M declares the following type of interests: consulting fees from EMC-REG International and AstraZeneca L.P declares the following type of interests: speaker fees (Novonordisk) C.C has received grant funding from the French Ministry of Health, the French National Research Agency as part of the future investment program integrated into France 2030, under grant agreement No. ANR-23-RHUS-06 (RHU TIPITCH), and consulting services with Bayer. She also reports membership of several data and safety monitoring boards for clinical trials, and Associate Editor of the Stroke journal.Disclosures:V.M, N.S, HH.T and T.G : noneA.M declares the following type of interests: consulting fees from EMC-REG International and AstraZenecaL.P declares the following type of interests: speaker fees (Novonordisk)C.C has received grant funding from the French Ministry of Health, the French National Research Agency as part of the future investment program integrated into France 2030, under grant agreement No. ANR-23-RHUS-06 (RHU TIPITCH), and consulting services with Bayer.She also reports membership of several data and safety monitoring boards for clinical trials, and Associate Editor of the Stroke journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}